Annual EBIT
-$385.67M$6.25M-1.65%
Summary
- Current Value
- As of today, RLAY annual EBIT is -$385.67M, down -1.65% on
- Historical Performance
- RLAY annual EBIT is down -69.90% over the past 3 years, and down -358.87% over the past 5 years
- All-Time High Comparison
- RLAY annual EBIT is currently -673.06% below its historical high of -$49.89M set on
- 3-Year Low Comparison
- RLAY annual EBIT is at its 3-year low
- Sector Comparison
- RLAY annual EBIT is higher than 3.38% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$385.67M | -1.6% | -69.9% | -358.9% | -673.1% | |
| Quarterly EBIT | -$80.39M | +16.6% | +2.7% | -119.6% | -390.1% | |
| TTM EBIT | -$327.09M | +17.2% | -11.1% | -180.5% | -1894.2% | |
| Price | $7.97 | +65.0% | -48.9% | -80.4% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $10.01M | -60.8% | +230.4% | +100.0% | +100.0% | |
| Annual EPS | -$2.36 | +15.3% | +38.2% | -182.1% | -335.5% | |
| Annual EBITDA | -$380.21M | -1.6% | -70.4% | -368.2% | -696.5% | |
| Annual Net Income | -$337.71M | +1.3% | +7.2% | -348.4% | -592.2% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$310.95M | N/A | -24.0% |
| 5Y | -$55.80M | N/A | -591.2% |
| All | -$49.89M | -673.1% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$385.67M | at low | |
| 5Y | -$385.67M | at low | |
| All | -$385.67M | at low |
EBIT History
| Year | Value | Change |
|---|---|---|
| -$385.67M | -1.6% | |
| -$379.42M | -22.0% | |
| -$310.95M | -37.0% | |
| -$227.01M | -306.9% |
| Year | Value | Change |
|---|---|---|
| -$55.80M | +33.6% | |
| -$84.05M | -68.5% | |
| -$49.89M | - |
FAQ
What is the current annual EBIT of RLAY?
As of today, RLAY annual EBIT is -$385.67M
What is 1-year change in RLAY annual EBIT?
RLAY annual EBIT is down -1.65% year-over-year
What is 3-year change in RLAY annual EBIT?
RLAY annual EBIT is down -69.90% over the past 3 years
How far is RLAY annual EBIT from its all-time high?
RLAY annual EBIT is currently -673.06% below its historical high of -$49.89M set on December 31, 2018
How does RLAY annual EBIT rank versus sector peers?
RLAY annual EBIT is higher than 3.38% of companies in Healthcare sector
When is RLAY next annual earnings release?
The next annual earnings release for RLAY is on
Quarterly EBIT
-$80.39M$3.54M-4.61%
Summary
- Current Value
- As of today, RLAY quarterly EBIT is -$80.39M, down -4.61% on
- Historical Performance
- RLAY quarterly EBIT is up +16.58% year-over-year, and up +2.71% over the past 3 years
- All-Time High Comparison
- RLAY quarterly EBIT is currently -329.77% below its historical high of $34.99M set on
- 3-Year Low Comparison
- RLAY quarterly EBIT is +28.31% above its 3-year low of -$112.13M reached on
- Sector Comparison
- RLAY quarterly EBIT is higher than 4.64% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | -$80.39M | -4.6% | +16.6% | +2.7% | -119.6% | |
| Annual EBIT | -$385.67M | – | -1.6% | -69.9% | -358.9% | |
| TTM EBIT | -$327.09M | +4.7% | +17.2% | -11.1% | -180.5% | |
| Price | $7.97 | +17.6% | +65.0% | -48.9% | -80.4% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | -100.0% | 0.0% | -100.0% | 0.0% | |
| Quarterly EPS | -$0.43 | -4.7% | +31.6% | +43.3% | +81.9% | |
| Quarterly EBITDA | -$79.64M | -5.0% | +16.2% | +2.4% | -123.1% | |
| Quarterly Net Income | -$74.15M | -5.4% | +15.8% | +11.9% | -105.5% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$76.85M | -4.6% | |
| 3Y | -$74.78M | -7.5% | |
| 5Y | $34.99M | N/A | -329.8% |
| All | $34.99M | -329.8% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$84.98M | N/A | +5.4% |
| 3Y | -$112.13M | +28.3% | |
| 5Y | -$112.13M | +28.3% | |
| All | -$112.13M | +28.3% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of RLAY?
As of today, RLAY quarterly EBIT is -$80.39M
What is RLAY quarterly EBIT most recent change?
RLAY quarterly EBIT was down -4.61% on September 30, 2025
What is 1-year change in RLAY quarterly EBIT?
RLAY quarterly EBIT is up +16.58% year-over-year
How far is RLAY quarterly EBIT from its all-time high?
RLAY quarterly EBIT is currently -329.77% below its historical high of $34.99M set on December 31, 2020
How does RLAY quarterly EBIT rank versus sector peers?
RLAY quarterly EBIT is higher than 4.64% of companies in Healthcare sector
When is RLAY next earnings release?
The next earnings release for RLAY is on
TTM EBIT
-$327.09M$15.98M+4.66%
Summary
- Current Value
- As of today, RLAY TTM EBIT is -$327.09M, up +4.66% on
- Historical Performance
- RLAY TTM EBIT is up +17.18% year-over-year, and down -11.09% over the past 3 years
- All-Time High Comparison
- RLAY TTM EBIT is currently -1894.18% below its historical high of -$16.40M set on
- 3-Year Low Comparison
- RLAY TTM EBIT is +17.18% above its 3-year low of -$394.96M reached on
- Sector Comparison
- RLAY TTM EBIT is higher than 4.10% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | -$327.09M | +4.7% | +17.2% | -11.1% | -180.5% | |
| Annual EBIT | -$385.67M | – | -1.6% | -69.9% | -358.9% | |
| Quarterly EBIT | -$80.39M | -4.6% | +16.6% | +2.7% | -119.6% | |
| Price | $7.97 | +17.6% | +65.0% | -48.9% | -80.4% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $8.36M | 0.0% | -16.5% | +393.0% | +100.0% | |
| TTM EPS | -$1.75 | +10.2% | +33.0% | +34.3% | +45.7% | |
| TTM EBITDA | -$322.79M | +4.5% | +17.1% | -11.1% | -185.3% | |
| TTM Net Income | -$297.59M | +4.5% | +13.8% | -2.5% | -166.7% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$327.09M | at high | |
| 3Y | -$310.95M | N/A | -5.2% |
| 5Y | -$55.80M | N/A | -486.2% |
| All | -$16.40M | -1894.2% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$385.67M | N/A | +15.2% |
| 3Y | -$394.96M | +17.2% | |
| 5Y | -$394.96M | +17.2% | |
| All | -$394.96M | +17.2% |
TTM EBIT History
FAQ
What is the current TTM EBIT of RLAY?
As of today, RLAY TTM EBIT is -$327.09M
What is RLAY TTM EBIT most recent change?
RLAY TTM EBIT was up +4.66% on September 30, 2025
What is 1-year change in RLAY TTM EBIT?
RLAY TTM EBIT is up +17.18% year-over-year
How far is RLAY TTM EBIT from its all-time high?
RLAY TTM EBIT is currently -1894.18% below its historical high of -$16.40M set on March 31, 2019
How does RLAY TTM EBIT rank versus sector peers?
RLAY TTM EBIT is higher than 4.10% of companies in Healthcare sector
When is RLAY next earnings release?
The next earnings release for RLAY is on
EBIT Formula
EBIT = − −
Data Sources & References
- RLAY Official Website www.relaytx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1812364/000119312525269601/0001193125-25-269601-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1812364/000095017025027756/0000950170-25-027756-index.htm
- RLAY Profile on Yahoo Finance finance.yahoo.com/quote/RLAY
- RLAY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rlay